TYK2 and neoplasm: Here we relate the transcriptome changes to phenotypical changes observed in TYK2-deficient (Tyk2−/−) and TYK2 kinase-inactive (Tyk2K923E) mice in naïve splenic immune cells and upon ex vivo IFN treatment or in vivo tumor transplant infiltration.